Cytokinetics, Incorporated - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CYTK Nasdaq 2836 www.cytokinetics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cytokinetics, Incorporated

Cytokinetics Presents Positive Aficamten Data for Obstructive HCM at European Heart Failure Congress - Jun 25th, 2025 2:09 am
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 17th, 2025 2:00 pm
Cytokinetics, Incorporated (CYTK) Price Target Lowered To $53 from $71 at JPMorgan - Jun 11th, 2025 6:23 pm
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program - Jun 10th, 2025 5:30 am
Cytokinetics (CYTK) Down 1.9% Since Last Earnings Report: Can It Rebound? - Jun 5th, 2025 9:30 am
Cytokinetics to Participate in the Jefferies Global Healthcare Conference - May 29th, 2025 2:00 pm
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress - May 18th, 2025 6:00 am
Revenue Downgrade: Here's What Analysts Forecast For Cytokinetics, Incorporated (NASDAQ:CYTK) - May 16th, 2025 5:38 am
Cytokinetics to Host Symposium on Contemporary Landscapes in Muscle Biology - May 15th, 2025 5:30 am
Cytokinetics Announces Positive Topline Results From MAPLE-HCM - May 13th, 2025 5:30 am
Cytokinetics Announces Four Upcoming Presentations at the European Society Of Cardiology Heart Failure 2025 Congress - May 8th, 2025 2:00 pm
Cytokinetics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - May 8th, 2025 4:18 am
Cytokinetics to Hold Annual Meeting of Stockholders - May 7th, 2025 2:00 pm
Cytokinetics Q1 Earnings Beat, Aficamten Target Action Date Extended - May 7th, 2025 11:11 am
Cytokinetics Inc (CYTK) Q1 2025 Earnings Call Highlights: Strong Start Amid Regulatory Challenges - May 7th, 2025 1:19 am
Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates - May 6th, 2025 3:05 pm
Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update - May 6th, 2025 2:00 pm
Why Cytokinetics, Inc. (CYTK) Went Down On Friday - May 3rd, 2025 4:37 am
FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months - May 2nd, 2025 1:37 pm
Cytokinetics reveals unexpected delay; AstraZeneca combo therapy hits in asthma - May 2nd, 2025 5:02 am